|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of a monoclonal antibody to PCSK9,REGN727/SAR236553,to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy:a phase 2 randomised controlled t显示文摘 | Stein EA Gipe D Bergeron J | | 0，，： | 1 |
| 2 | Effect of a monoclonal antibody to PCSKg, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled显示文摘 | STEIN EA GIPE 13 BERGERON J | 2012 | Lancet2012，380，9836： | 1 |
| 3 | Effect of a monoelonal antibody to PCSK9, REGN727/SAR236553, to reduce low- density lipoprotein cholesterol in patients with heterozygous familial hypereholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial显示文摘 | STEIN EA GIPE D BERGERON J | 2012 | Lancet2012，380，9836： | 1 |
| 4 | Embryo transfer in water buffaloes (Bubalus bubalis)显示文摘 | Drost M Wright J M Gipe W S | 1983 | Theriogenology1983，20，： | 1 |
| 5 | Creativity as a mediating variable in inferential reading comprehension显示文摘 | Anderson B.V Gipe J.P | | 0，，4： | 1 |
| 6 | Effect of a monoclonal anti- body to PCSKg, REGN727/SAR236553, to reduce low-density lipo- protein cholesterol in patients with heterozygous familial hypereho- lesterolaemia on stable statin dose with or without ezetimibe thera- py: a phase 2 randomised controlled trial 显示文摘 | Stein EA Gipe D Bergeron J | 2012 | Lancet2012，380，9836： | 1 |
| 7 | Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial 显示文摘 | Stein EA Gipe D bergeron J et aJ | 2012 | Lancet2012，380，9836： | 1 |
| 8 | Effect of a monoclonal an-tibody to PCSK9,REGN727/SAR236553,to reduce low-densitylipoprotein cholesterol in patients with heterozygous familial hyper-cholesterolaemia on stable statin dose with or without ezetimibe the-rapy:a phase 2 randomised controlled trial显示文摘 | Stein EA Gipe D Bergeron J | 2012 | Lancet2012，380，9836： | 1 |
| 9 | Effect of a monoclonal antibody to PCSK9,REGN 727/SAR 236553,to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy:a phase 2 randomised controlled trial显示文摘 | STEIN EA GIPE D BERGERON J | 2012 | Lancet2012，380，9836： | 1 |
| 10 | Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial 显示文摘 | Stein EA Gipe D Bergeron J | 2012 | Lancet2012，380，9836： | 1 |
| 11 | Effect of a monoclonal antibody to PCSK9,REGN727/SAR236553,to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy:aphase 2randomised controlled trial显示文摘 | STEIN E A GIPE D BERGERON J | 2012 | Lancet2012，380，： | 1 |
| 12 | Effect of a monoclonal antibody to PCSK9,REGN727/SAR236553,to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy:aphase 2randomised controlled trial显示文摘 | STEIN E A GIPE D BERGERON J | 2012 | Lancet2012，380，： | 1 |
| 13 | Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553,to reduce low-density lipopro- tein cholesterol in patients with heterozygous familial hypereholes- terolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial显示文摘 | Stein EA Gipe D Bergeron J | 2012 | Lancet2012，380，9836： | 1 |
| 14 | Rotation,Solvation,and Hydrogen Bonding of Aqueous Ammonium Ion显示文摘 | PERRIN C L GIPE R K | 1986 | J Am Chem Soc1986，108，5： | 1 |
| 15 | Effect of a monoclonal antibodyto PCSK9, REGN727/SAR236553, to reduce low- density lipoproteincholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetindbe therapy: a phase 2 randomised controlled trial显示文摘 | STEIN EA GIPE D BERGERON J | 2012 | Lancet2012，380，9836： | 1 |
| 16 | Wind power显示文摘 | Gipe P | 2004 | Wind Engineering2004，28，5： | 1 |
| 17 | Effect of a monoclo- nal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable sta- tindose with or without ezetimibe therapy: a phase 2 ran- domised controlled trial显示文摘 | Stein EA Gipe D Bergeron J | 2012 | Lancet2012，380，9836： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员